These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3029064)

  • 21. The amino acid sequence of an active site peptide from the H,K-ATPase of gastric mucosa.
    Farley RA; Faller LD
    J Biol Chem; 1985 Apr; 260(7):3899-901. PubMed ID: 2984187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformation-dependent inhibition of gastric H+,K+-ATPase by SCH 28080 demonstrated by mutagenesis of glutamic acid 820.
    Swarts HG; Hermsen HP; Koenderink JB; Willems PH; de Pont JJ
    Mol Pharmacol; 1999 Mar; 55(3):541-7. PubMed ID: 10051539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
    Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
    Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor.
    Hioki Y; Takada J; Hidaka Y; Takeshita H; Hosoi M; Yano M
    Arch Int Pharmacodyn Ther; 1990; 305():32-44. PubMed ID: 2173509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody HK4001 completely inhibits K(+)-dependent ATP hydrolysis and H+ transport of hog gastric H+,K(+)-ATPase.
    Asano S; Tabuchi Y; Takeguchi N
    J Biochem; 1989 Dec; 106(6):1074-9. PubMed ID: 2560778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Papain fragmentation of the gastric (H+ + K+)-ATPase.
    Saccomani G; Mukidjam E
    Biochim Biophys Acta; 1987 Mar; 912(1):63-73. PubMed ID: 3030430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
    Nagaya H; Satoh H
    Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible inhibitions of gastric H+,K(+)-ATPase by scopadulcic acid B and diacetyl scopadol. New biochemical tools of H+,K(+)-ATPase.
    Asano S; Mizutani M; Hayashi T; Morita N; Takeguchi N
    J Biol Chem; 1990 Dec; 265(36):22167-73. PubMed ID: 2176205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of H+K+ATPase by SCH 28080 and SCH 32651.
    Scott CK; Sundell E
    Eur J Pharmacol; 1985 Jun; 112(2):268-70. PubMed ID: 2993001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of K+ with gastric parietal cells and gastric ATPase.
    Sachs G; Berglindh T; Rabon E; Wallmark B; Barcellona ML; Stewart HB; Saccomani G
    Ann N Y Acad Sci; 1980; 358():118-37. PubMed ID: 6259985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCH 28080 is a more selective inhibitor than SCH 32651 at the K+ site of gastric K+/H+-ATPase.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1987 Jul; 139(3):349-52. PubMed ID: 2822435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Syrian hamster gastric mucosal H+,K+-ATPase.
    Chatterjee PK; Das PK
    Mol Cell Biochem; 1995 Jul; 148(2):95-103. PubMed ID: 8594424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate.
    Im WB; Blakeman DP; Mendlein J; Sachs G
    Biochim Biophys Acta; 1984 Feb; 770(1):65-72. PubMed ID: 6320882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
    Reenstra WW; Shortridge B; Forte JG
    Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function and structure of parietal cells after H+-K+-ATPase blockade.
    Fryklund J; Helander HF; Elander B; Wallmark B
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G399-407. PubMed ID: 2831735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of verapamil on gastric acid secretion in vitro and in vivo.
    Herling AW; Ljungström M
    Eur J Pharmacol; 1988 Nov; 156(3):341-50. PubMed ID: 2850932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of gastric H+,K(+)-ATPase and acid secretion by cassigarol A, a polyphenol from Cassia garrettiana Craib.
    Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
    Biochem Pharmacol; 1992 Jul; 44(1):33-7. PubMed ID: 1321629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ethanol on acid secretion by isolated gastric glands from rabbit.
    Reichstein BJ; Okamoto C; Forte JG
    Gastroenterology; 1986 Aug; 91(2):439-47. PubMed ID: 3013711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
    Kaminski JJ; Wallmark B; Briving C; Andersson BM
    J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.